Hepatic Hydrothorax
Conditions
Brief summary
Hepatic hydrothorax (HH) is a pleural effusion that develops in a patient with cirrhosis and portal hypertension in the absence of cardiopulmonary disease (Lv et al., 2018). Several factors are known to contribute to the development of effusion; the most accepted mechanism of which is the direct delivery of ascitic fluid from the peritoneal cavity to the pleural cavity by positive intra-abdominal pressure and a negative intrathoracic pressure of the pleural cavity through microscopic congenital diaphragmatic defects (Han et al., 2022).
Interventions
PROCEDUREThoracocentasis
patients will be submitted to diagnostic pleural fluid study, chest x-ray, liver function and blood picture
Sponsors
Sohag University
Study design
Allocation
NA
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Patients who met the following inclusion criteria were enrolled: * Liver cirrhosis (with or without hepatocellular carcinoma). * Hepatic hydrothorax (bilateral or unilateral).
Exclusion criteria
* patients with a pleural effusion due to a condition other than HH. * who had a diagnosis of tuberculosis pleurisy, parapneumonic effusion, inflammatory pleuritis, other neoplasms, and congestive heart failure.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| percentage of empyema in patients with hepatic hydrothorax after thoracocentesis | 12 months | Patients with hepatic hydrothorax that undergo repeated thoracocentesis will be monitored for presence of any side effects as empyema |
Countries
Egypt
Contacts
Primary ContactAya A AbdElkareem, Resident
Backup ContactKhairy H Morsy, Professor
Outcome results
None listed